Alnylam Pharmaceuticals Inc. technical analysis
Technical analysis of Alnylam Pharmaceuticals Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a US biopharmaceutical company developing therapies based on RNA interference (RNAi). It focuses on treatments for rare genetic diseases and other conditions.
Description generated automatically from public sources; it may be inaccurate or out of date.
Alnylam Pharmaceuticals Inc.: latest session data
Closing values for October 21, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
234.18 $
−2.59%
50 sessions
239.11 $
−4.60%
200 sessions
291.78 $
−21.82%
Session levels
s2
223.65
Support
s1
227.18
Support
pivot
233.07
Pivot
r1
236.60
Resistance
r2
242.49
Resistance
How to read it
In the October 21, 2026 session Alnylam Pharmaceuticals Inc. closed lower at 228.12 $, −1.12% versus the previous session.
The price sits below every moving average observed: −2.59% against the 21-session average, −4.60% against the 50 and −21.82% against the 200.
The 14-period RSI reads 44.1, in neutral territory.
MACD stands at -3.868 against a signal line at -4.403: the histogram is positive (+0.535).
ADX reads 12.2, indicating weak directionality.
Levels computed on the latest session place supports at 227.18 and 223.65 $ and resistances at 236.60 and 242.49 $, around a pivot of 233.07.
The average daily range (ATR) is 8.646 $, or 3.79% of price.
Turnover was 147.4K shares, 12% of the 20-session average.
Over the last twelve months the price ranged between 197.81 and 380.00 $, and today stands −39.97% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the ALNY analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Alnylam Pharmaceuticals Inc.
How is Alnylam Pharmaceuticals Inc. analysed technically?
Technical analysis of Alnylam Pharmaceuticals Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Alnylam Pharmaceuticals Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Alnylam Pharmaceuticals Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Alnylam Pharmaceuticals Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.